Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Munker

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Leukemia & Lymphoma|February 26, 1998
Soluble CD95 in the serum of patients with low and intermediate grade malignant lymphomas: absence of prognostic correlationsR Munker, A Younes, F Cabanillas, et al.
International Journal of Oncology|May 5, 2011
Second malignanciesR Munker, E Hiller, A Melnyk, et al.
Leukemia|September 1, 1996
Soluble FAS (CD95) is not elevated in the serum of patients with myeloid leukemias, myeloproliferative and myelodysplastic syndromesR Munker, G Midis, L Owen-Schaub, et al.
Deutsche Medizinische Wochenschrift (1946)|July 26, 1991
[Lennert's lymphoma and glomerulonephritis]R Munker, W Nathrath, W Permanetter, et al.
Leukemia & Lymphoma|December 30, 1998
Vitamin D analogs, leukemia and WAF1R Munker, W Zhang, E Elstner, et al.
Nature|September 4, 1986
Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factorR Munker, J Gasson, M Ogawa, et al.
Oncology Reports|February 19, 1999
P53-immunoreactive cells in benign and malignant effusions: diagnostic value using a panel of monoclonal antibodies and comparison with CEA-stainingO J Stoetzer, R Munker, M Darsow, et al.
Blood|December 1, 1987
In vitro interaction of recombinant tumor necrosis factor alpha and all-trans-retinoic acid with normal and leukemic hematopoietic cellsA Tobler, R Munker, D Heitjan, et al.
Annals of Hematology|July 1, 1992
TNF induces cytoplasmic vesicles in actinomycin D-treated K 562 cellsR Munker, L Greither, M Darsow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Bone marrow involvement in Hodgkin's disease: an analysis of 135 consecutive cases. German Hodgkin's Lymphoma Study GroupR Munker, D Hasenclever, O Brosteanu, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Leukemia & Lymphoma|February 26, 1998
Soluble CD95 in the serum of patients with low and intermediate grade malignant lymphomas: absence of prognostic correlationsR Munker, A Younes, F Cabanillas, et al.
International Journal of Oncology|May 5, 2011
Second malignanciesR Munker, E Hiller, A Melnyk, et al.
Leukemia|September 1, 1996
Soluble FAS (CD95) is not elevated in the serum of patients with myeloid leukemias, myeloproliferative and myelodysplastic syndromesR Munker, G Midis, L Owen-Schaub, et al.
Deutsche Medizinische Wochenschrift (1946)|July 26, 1991
[Lennert's lymphoma and glomerulonephritis]R Munker, W Nathrath, W Permanetter, et al.
Leukemia & Lymphoma|December 30, 1998
Vitamin D analogs, leukemia and WAF1R Munker, W Zhang, E Elstner, et al.
Nature|September 4, 1986
Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factorR Munker, J Gasson, M Ogawa, et al.
Oncology Reports|February 19, 1999
P53-immunoreactive cells in benign and malignant effusions: diagnostic value using a panel of monoclonal antibodies and comparison with CEA-stainingO J Stoetzer, R Munker, M Darsow, et al.
Blood|December 1, 1987
In vitro interaction of recombinant tumor necrosis factor alpha and all-trans-retinoic acid with normal and leukemic hematopoietic cellsA Tobler, R Munker, D Heitjan, et al.
Annals of Hematology|July 1, 1992
TNF induces cytoplasmic vesicles in actinomycin D-treated K 562 cellsR Munker, L Greither, M Darsow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Bone marrow involvement in Hodgkin's disease: an analysis of 135 consecutive cases. German Hodgkin's Lymphoma Study GroupR Munker, D Hasenclever, O Brosteanu, et al.
Pageof 9